An agenda for Clinical Trials: clinical trials in the genomic era
- 1 October 2004
- journal article
- other
- Published by SAGE Publications in Clinical Trials
- Vol. 1 (5), 468-470
- https://doi.org/10.1191/1740774504cn046xx
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1Journal of Clinical Oncology, 2004
- Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2Journal of Clinical Oncology, 2004
- Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray dataBritish Journal of Cancer, 2003
- Estimating Dataset Size Requirements for Classifying DNA Microarray DataJournal of Computational Biology, 2003
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- A Paradigm for Class Prediction Using Gene Expression ProfilesJournal of Computational Biology, 2002
- Evaluating the Potential Usefulness of New Prognostic and Predictive Indicators on Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1993
- Why do so many prognostic factors fail to pan out?Breast Cancer Research and Treatment, 1992